Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

ART in low-resource settings: how to do more with less.

Koole O, Colebunders R.

Lancet. 2010 Aug 7;376(9739):396-8. doi: 10.1016/S0140-6736(10)61020-3. Epub 2010 Jul 15. No abstract available.

PMID:
20638119
2.

Bone health and HIV in resource-limited settings: a scoping review.

Matovu FK, Wattanachanya L, Beksinska M, Pettifor JM, Ruxrungtham K.

Curr Opin HIV AIDS. 2016 May;11(3):306-25. doi: 10.1097/COH.0000000000000274. Review.

PMID:
27023284
3.

Management of HIV in resource limited settings.

McCutchan JA.

Curr Opin Infect Dis. 2009 Oct;22(5):464-70. doi: 10.1097/QCO.0b013e3283308fe2. Review.

PMID:
19730283
4.

Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment.

Little K, Thorne C, Luo C, Bunders M, Ngongo N, McDermott P, Newell ML.

Curr HIV Res. 2007 Mar;5(2):139-53. Review.

PMID:
17346131
5.

Changing roles and responses of health care workers in HIV treatment and care.

Rajaraman D, Palmer N.

Trop Med Int Health. 2008 Nov;13(11):1357-63. doi: 10.1111/j.1365-3156.2008.02176.x. Review.

6.

HIV and noncommunicable disease comorbidities in the era of antiretroviral therapy: a vital agenda for research in low- and middle-income country settings.

Narayan KM, Miotti PG, Anand NP, Kline LM, Harmston C, Gulakowski R 3rd, Vermund SH.

J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S2-7. doi: 10.1097/QAI.0000000000000267. Review.

PMID:
25117958
7.

Antiretroviral therapy in the developing world.

Chulamokha L, DeSimone JA, Pomerantz RJ.

J Neurovirol. 2005;11 Suppl 1:76-80. Review. No abstract available.

PMID:
15960241
8.

Enhancing linkage and retention in HIV care: a review of interventions for highly resourced and resource-poor settings.

Okeke NL, Ostermann J, Thielman NM.

Curr HIV/AIDS Rep. 2014 Dec;11(4):376-92. doi: 10.1007/s11904-014-0233-9. Review.

PMID:
25323298
9.

Predicting the impact of antiretrovirals in resource-poor settings: preventing HIV infections whilst controlling drug resistance.

Blower S, Ma L, Farmer P, Koenig S.

Curr Drug Targets Infect Disord. 2003 Dec;3(4):345-53. Review.

PMID:
14754434
10.

Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries.

De Luca A, Hamers RL, Schapiro JM.

J Infect Dis. 2013 Jun 15;207 Suppl 2:S63-9. doi: 10.1093/infdis/jit109. Review.

PMID:
23687291
11.

Antiretroviral treatment in low-resource settings: what has changed in the last 10 years and what needs to change in the coming years?

Mehta M, Semitala F, Lynen L, Colebunders R.

Expert Rev Anti Infect Ther. 2012 Nov;10(11):1287-96. doi: 10.1586/eri.12.129. Review.

PMID:
23241186
12.

[The HIV pandemic in the year 2007, an overview].

Bartelsman M, Veeken H.

Ned Tijdschr Geneeskd. 2007 Dec 1;151(48):2655-60. Review. Dutch.

PMID:
18179081
13.

Treatment of human immunodeficiency virus (HIV) in children using antiretroviral drugs.

Anabwani GM, Woldetsadik EA, Kline MW.

Semin Pediatr Infect Dis. 2005 Apr;16(2):116-24. Review.

PMID:
15825142
14.

HIV and cardiovascular risk.

Moyle G, Randell P.

Clin Med (Lond). 2008 Jun;8(3):315-8. Review. No abstract available.

PMID:
18624046

Supplemental Content

Support Center